PAA 3.03% 17.0¢ pharmaust limited

Ann: Appointment of Non-Executive Director, page-18

  1. 2,287 Posts.
    lightbulb Created with Sketch. 2792
    That's how I'm seeing it ... acknowledging my own confirmation bias..

    I'm confident, those in the know, are convinced MPL works , and is safe.
    The calibre of appointments in SAB, and recent hires, would have scrutinised the available data before committing.
    Highly knowledgeable in their fields, the data was obviously compelling enough to commit to PAA.

    So now it's about execution, and how to leverage value & GTM.

    The new board not only has expertise, but IMHO, charisma in spades.
    Unfortunately in this world you cannot leave the science "to do the talking" & create value. You need a highly impactful & united senior management & board, PR company etc - wowing all & sundry ... and I believe that is what shareholders are about to witness.

    The $'s to execute STRIKE will be sorted soon enough ... TBH I'm not the least bit concerned about this aspect.
    And good luck if you are waiting to accumulate a position on any financing discount the market offers ... who will be selling at a 5% - 10% discount knowing financing is sorted and it's likely to be a rapid SP appreciation from that point onwards !

    Exciting times.
    All IMO
    Last edited by Quiltman: 17/06/24
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.0¢
Change
0.005(3.03%)
Mkt cap ! $82.65M
Open High Low Value Volume
17.0¢ 18.0¢ 16.8¢ $151.1K 877.6K

Buyers (Bids)

No. Vol. Price($)
4 54714 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 371375 7
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.